Brief: Medmix AG Says HY 2026 Revenue Declined By 1.6% Organically
BRIEF-Medmix AG Says HY 2026 Revenue Declined By 1.6% Organically July 23 (Reuters) - medmix AG MEDX.S:
MEDMIX AG - HY 2026 REVENUE DECLINED BY 1.6% ORGANICALLY
MEDMIX AG - HY 2026 TOTAL REVENUE CHF 214.4 MILLION
MEDMIX AG - HY 2026 NET INCOME DECREASED BY CHF 6.1 MILLION TO CHF 0.8 MILLION
MEDMIX AG - FOR FULL YEAR 2026, WE EXPECT FLAT TO LOW SINGLE DIGIT ORGANIC REVENUE GROWTH AND AN ADJUSTED EBITDA MARGIN OF AROUND 20%.
Source text: [ID:]
Further company coverage: MEDX.S
((Reuters.Briefs@thomsonreuters.com;))